Cross Country Healthcare, Inc. (NASDAQ:CCRN) Receives Consensus Rating of "Hold" from Analysts

Cross Country Healthcare, Inc. (NASDAQ:CCRN - Get Free Report) has earned a consensus recommendation of "Hold" from the six brokerages that are currently covering the firm, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a hold recommendation. The average 1 year price target among analysts that have covered the stock in the last year is $17.93.

CCRN has been the topic of several research analyst reports. StockNews.com initiated coverage on shares of Cross Country Healthcare in a research report on Thursday. They set a "hold" rating on the stock. JMP Securities reissued a "market perform" rating on shares of Cross Country Healthcare in a research report on Thursday, February 6th. UBS Group dropped their target price on shares of Cross Country Healthcare from $18.61 to $16.50 and set a "neutral" rating on the stock in a research report on Tuesday. Finally, Barrington Research reissued a "market perform" rating and set a $18.61 target price on shares of Cross Country Healthcare in a research report on Friday, March 14th.

Institutional Investors Weigh In On Cross Country Healthcare

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Magnetar Financial LLC acquired a new position in shares of Cross Country Healthcare in the fourth quarter valued at approximately $41,421,000. Alliancebernstein L.P. lifted its position in shares of Cross Country Healthcare by 82.4% during the 1st quarter. Alliancebernstein L.P. now owns 2,343,484 shares of the business services provider's stock worth $34,894,000 after buying an additional 1,058,544 shares during the last quarter. Alpine Associates Management Inc. lifted its position in shares of Cross Country Healthcare by 115.6% during the 1st quarter. Alpine Associates Management Inc. now owns 1,252,524 shares of the business services provider's stock worth $18,650,000 after buying an additional 671,492 shares during the last quarter. AQR Arbitrage LLC purchased a new stake in Cross Country Healthcare in the 4th quarter valued at $10,851,000. Finally, Chicago Capital Management LLC purchased a new stake in Cross Country Healthcare in the 4th quarter valued at $7,300,000. 96.03% of the stock is currently owned by institutional investors and hedge funds.

Cross Country Healthcare Stock Up 0.3%

NASDAQ CCRN opened at $13.99 on Friday. The firm has a market cap of $458.63 million, a PE ratio of -279.74, a price-to-earnings-growth ratio of 3.32 and a beta of 0.38. The company has a 50 day moving average price of $14.40 and a 200 day moving average price of $15.47. Cross Country Healthcare has a 52 week low of $9.58 and a 52 week high of $18.50.

Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The business services provider reported $0.06 EPS for the quarter, topping the consensus estimate of $0.04 by $0.02. Cross Country Healthcare had a negative net margin of 0.12% and a positive return on equity of 5.38%. The business's revenue for the quarter was down 22.6% on a year-over-year basis. During the same quarter last year, the firm posted $0.19 earnings per share. On average, equities research analysts anticipate that Cross Country Healthcare will post 0.53 earnings per share for the current fiscal year.

About Cross Country Healthcare

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.